Medscape |
Cancer Drug Imatinib May Slow New-Onset Type 1 Diabetes
Medscape Type 1 diabetes results from the autoimmune destruction of insulin-producing beta cells in the pancreas, and the question this type of research tries to answer is "What can we do to make beta cells great again?" Dr Gitelman explained in his presentation. |
Social Plugin